Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

ACC.22 kicked off on Saturday, April 2, in Washington, D.C.

Salt restrictions, PCI breakthroughs and a social media primer for cardiologists: Day 1 at ACC.22

Explore our on-the-ground coverage of the first day of ACC.22.

More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.

Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement.

Older LAAO patients, especially women, face a higher risk of complications

Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.

Same-day discharge after TAVR is feasible and safe, new Cleveland Clinic study confirms

Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success.

Interventional cardiology procedure in a cath lab at Beaumont Hospital.

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief.

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Data from the FOURIER trial helped clinicians learn more about this popular PCSK9 inhibitor.

Distal radial access consistently lowers risk of artery occlusion during PCI

The new meta-analysis, published in the American Journal of Cardiology, includes data from 16 different studies.

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027